Katarzyna Barczyk-Popiolek
Smętna 12 Str
Krakow, MA 31343, Poland
Krakow, MA 31343, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Preclinical characterization of the efficacy and safety of histamine H3 receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment.
Journal: European journal of pharmacology
Published: February 17, 2026
Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 18, 2024
Escitalopram reverses anxiety-like and despair behavior and affects endocannabinoid-related genes expression in the brain of adolescent male rats subjected to early life stress.
Journal: Neuroscience
Published: August 26, 2024
AR71, Histamine H3 Receptor Ligand-In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action).
Journal: International journal of molecular sciences
Published: June 21, 2024
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain.
Journal: Journal of medicinal chemistry
Published: July 07, 2023
Anti-inflammatory effects of new human histamine H3 receptor ligands with flavonoid structure on BV-2 neuroinflammation.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: February 07, 2022
Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology.
Journal: Scientific reports
Published: January 08, 2021
Traumatic brain injury in mice induces changes in the expression of the XCL1/XCR1 and XCL1/ITGA9 axes.
Journal: Pharmacological reports : PR
Published: July 29, 2020
The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia.
Journal: Molecular and cellular probes
Published: July 28, 2020
CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
Journal: European journal of pharmacology
Published: January 17, 2020
The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
Journal: Immunology
Published: October 30, 2019
Last Updated: 09/26/2026